BOMM Medical's IPO Advances to Listing Committee Approval Stage
Deep News
Yesterday
Based on the latest disclosure from the Shenzhen Stock Exchange, on September 16, 2026, Guangdong BOMM Medical Technology Co., Ltd. saw its IPO status shift from under inquiry to approved at the listing committee review meeting.
The change indicates that the company's initial public offering application has successfully passed the review process, marking a significant milestone in its path toward listing on the exchange.
This update reflects the progress of the regulatory assessment, where the listing committee has given its nod to the company's offering proposal, subject to any further administrative procedures required before the final listing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.